FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCOSCIENS Biopharma Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CSCI.TO
COSCIENS Biopharma Inc. Stock AnalysisComprehensive stock analysis for COSCIENS Biopharma Inc. (CSCI.TO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CSCI.TO
  1. Home
  2. Stocks
  3. COSCIENS Biopharma Inc.
CS

COSCIENS Biopharma Inc.

🇨🇦CSCI.TO•TSX
CS

COSCIENS Biopharma Inc.

🇨🇦CSCI.TO•TSX
Market cap
$8.58M

Your view on CSCI.TO

Mkt Cap
$8.58M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About COSCIENS Biopharma Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Peter Harry Puccetti
Headquarters
22 Adelaide Street West, Toronto, ON, CA
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Peter Harry Puccetti
Headquarters
22 Adelaide Street West, Toronto, ON, CA
Description

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments.

The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries.

It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network.

It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta.

The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for COSCIENS Biopharma Inc.. Starting points for COSCIENS Biopharma Inc.: EPS -C$6.43, beta 1.80 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for COSCIENS Biopharma Inc.. Trailing twelve-month EPS for COSCIENS Biopharma Inc. stands at -C$6.43. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026

Buy

Analyst ratings

6 ratings
  • Strong Buy0
  • Buy4
  • Hold1
  • Sell1
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2017Next yearYear to Dec 2018
Average estimate−$5.33−$5.33−$424.09$114.34
Lowest estimate−$5.33−$5.33−$424.09$114.34
Highest estimate−$5.33−$5.33−$424.09$114.34
Number of analysts1111
A year ago−$6.30−$2.011——
Growth vs a year ago+15.4%———

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2017Next yearYear to Dec 2018
Average estimate$546056.00$546056.00$870837.00$25.82M
Lowest estimate$546056.00$546056.00$870837.00$25.82M
Highest estimate$546056.00$546056.00$870837.00$25.82M
Number of analysts1111
A year ago$1.79M$1.86M——
Growth vs a year ago−69.5%−70.6%——
Recent rating and target changes (9)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for COSCIENS Biopharma Inc.. COSCIENS Biopharma Inc. has reported as a listed company since 1996. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CSCI.TO12 companies
More Medical - Pharmaceuticals companies
TickerTypeCompanySectorExchangeMkt cap
ETBIEastgate Biotech Corp.HealthcareOTC$2.1M
EVAHFEGF Theramed Health Corp.HealthcareOTC$602,324
FITXCreative Edge Nutrition, Inc.HealthcareOTC$47,480
FSPMFusionPharm, Inc.HealthcareOTC$1,259
GCANThe Greater Cannabis Company, Inc.HealthcareOTC$207,059
GEATFRadiko Holdings Corp.HealthcareOTC$4,453
GEDSFGedeon Richter PLCHealthcareOTC$4.5B
GHTIG-H-3 International Inc.HealthcareOTC—
GRPIGrupo International Inc.HealthcareOTC$1,043
GSACGelStat CorporationHealthcareOTC$247,192
GWLLGoldenwell Biotech, Inc.HealthcareOTC$104.0M
HADVHealth Advance Inc.HealthcareOTC$48,284
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for COSCIENS Biopharma Inc.. Coverage tracks COSCIENS Biopharma Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of COSCIENS Biopharma Inc.

CSCI.TO AnalysisWeak
Past
1
Growth
1
Health
3
Profit
1
Value
1